Showing results (351-360 of 449) with videos related to

Sort By:
Pageof 45
Frontiers in Immunology|November 9, 2023
Impact of a booster dose on SARS-CoV2 mRNA vaccine-specific humoral-, B- and T cell immunity in pediatric stem cell transplant recipientsLinda Marie Laura Thole, Laura Tóth, Vanessa Proß, et al.
United European Gastroenterology Journal|February 16, 2025
High Incidence and Impact of Suspected Exocrine Pancreatic Insufficiency in Patients Post-Hematopoietic Stem Cell Transplantation: A Single-Center Prospective Observational StudyMichael Launspach, Aurika Mindermann, Joachim Schulz, et al.
Oncogene|April 10, 2012
MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cellsJ H Schulte, S Lindner, A Bohrer, et al.
Nature Communications|April 29, 2018
Towards ultrafast dynamics with split-pulse X-ray photon correlation spectroscopy at free electron laser sourcesW Roseker, S O Hruszkewycz, F Lehmkühler, et al.
The Lancet. Oncology|November 15, 2021
Ceritinib in paediatric patients with anaplastic lymphoma kinase-positive malignancies: an open-label, multicentre, phase 1, dose-escalation and dose-expansion studyMatthias Fischer, Lucas Moreno, David S Ziegler, et al.
Oncogene|December 1, 2009
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumorsP Mestdagh, E Fredlund, F Pattyn, et al.
The Journal of Pathology|October 16, 2008
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcomaN Friedrichs, J Küchler, E Endl, et al.
Antimicrobial Agents and Chemotherapy|August 18, 2025
Cytomegalovirus prophylaxis with letermovir in pediatric (birth to <18 years of age) hematopoietic cell transplant recipients: pharmacokinetics, efficacy, and safety results of a Phase 2b studyAndreas H Groll, Lara Danziger-Isakov, Aharon Gefen, et al.
International Journal of Cancer|July 22, 2014
miR-542-3p exerts tumor suppressive functions in neuroblastoma by downregulating SurvivinKristina Althoff, Sven Lindner, Andrea Odersky, et al.
Frontiers in Immunology|April 17, 2020
Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4<sup>+</sup> CAR T Cell EfficacySolin Ali, Karin Toews, Silke Schwiebert, et al.
Pageof 45